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This cross-sectional study aimed at identifying the most common attributions of their mental disorder in a Mexican patients who
have experienced psychosis and their relatives and exploring how having experienced or not characteristic psychotic symptoms
and their present clinical status might affect their etiological attributions. Past and current symptom profiles of 66 patients were
as assessed with the SCID-I (Structured Clinical Interview for DSM-IV Axis I Disorders) and the PANSS (Positive and Negative
Syndrome Scale), respectively. The etiological attribution of psychosis of patients (𝑛 = 62) and the relatives (𝑛 = 65) was assessed
with the Angermeyer andKlusmann scale comprising 30 items into five categories: biology, personality, family, society, and esoteric.
Patients and relatives attribute psychosis mainly to social factors. Relatives’ attributions were not influenced by clinical profile of
patients, whereas in the case of patients it was only current clinical status that showed a difference, with those in nonremission
scoring higher personality and family factors. Acknowledging patients’ and relatives’ beliefs about mental disorders at onset and
later on is particularly important in psychosis, a mental condition with severe and/or persistent symptoms, in order to promote
better involvement in treatment and in consequence efficacy and recovery.
1. Introduction
People’s beliefs about health and illness clearly affect their
behavior; for instance, they can acknowledge a possible dis-
order and request assistance [1, 2] or agree on the benefits
of a proposed treatment and then willingly adhere to it [3–
5]. As a result, etiological attribution of psychosis has been
a major research focus in both patients [2, 6–10] and their
relatives [11–16]. How individual interprets disorder occur-
rence influences the pathways he/she follows when seeking
help and how they deal with symptoms, with or without
treatment. Beliefs about amental disorder’s etiologymay also
affect patient emotional response.This is particularly the case
in schizophrenia spectrum disorders, the etiology of which
is still unclear [17, 18]. The etiology of psychosis has been
attributed to social, personality, family, biological, and even
esoteric factors, and these beliefs may influence the expec-
tations patients and their relatives have regarding prognosis
and commitment to treatment [7, 8, 11].
Once under clinical treatment, patients and their relatives
are usually provided with orientation about the patient’s con-
dition, possible diagnosis, treatment, and prognosis. Their
previous beliefs (accurate or not) are integrated with the
new information presented by mental health professionals.
Schizophrenia spectrum disorder onset patterns are diverse
(i.e., acute or insidious and mild to severe) as is disorder evo-
lution, which can vary from full recovery to chronic deterio-
rating progression [19]. A psychotic disorder’s long-term pat-
tern can be fairly well established about five years after onset.
The two to five years after the first psychotic episode, the so-
called “critical period,” constitute a crucial time window in
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whichmost patients are likely to relapse and/or present resid-
ual symptoms. After this period, psychosis intensity appears
to plateau and follow a more stable course [20, 21]. Attri-
bution of psychosis in patients and in their relatives is a
factor influencing pathways to care [8, 10, 16] and treatment
adherence [4, 5, 14] and consequently affects prognosis and
evolution. As psychosis follows its course, however, these
beliefs can also transform in response to the experience of
the disorder, a dynamic that has received little attention. The
studies addressing beliefs about the etiology of psychosis, in
patients and their relatives together, are scarce [11, 22]; the
same holds true for studies in Latin America.
Using a sample of patients from a mental health hospital
in Mexico, the present study aimed to (1) identify the most
common factors to which patients who have experienced
psychosis and their relatives attribute themental disorder and
(2) explore the possible effect of the experience of specific
characteristic psychotic symptoms in the course of psychosis
and their present clinical status on etiological attributions.
Understanding how patients and their relatives interpret
the mental disorder is particularly important in psychosis
given that symptoms are often severe and/or persistent and
may require long-term treatment. Even when the individual
has partially or totally recovered, the patient’s and relatives’
attributions can play an important role in awareness of mild
signs of the disorder, either in themselves or in others, and
how they proceed in response. Exploring etiological attribu-
tions in diverse samples allows cross-cultural comparisons
and identification of similarities and differences. Compre-
hending specific etiological attributions and how they relate
to the clinical profile can contribute to better interventions
that target these beliefs and their management with the
overall goal of improving well-being in the patient and their
relatives.
2. Methods
This cross-sectional study received formal authorization and
ethical approval from all relevant hospital committees. The
protocol adhered to international [23] and national [24]
ethical standards for studies with minimal risk. Participants
were recruited from a public psychiatric hospital providing
mental health services to anyone in need regardless of place
of residence and medical insurance status.
Administrative policy at the hospital dictates that cases/
files be expunged from the archives once ten years have
passed from the last time the patient received attention, either
as an outpatient or as an inpatient. Current clinical files were
reviewed to identify patients meeting four inclusion criteria:
(i) age of 16–45 years at onset; (ii) a primary current DSM-IV-
TR [25] diagnosis of schizophrenia or other schizophrenia
spectrumpsychotic disorders; (iii) at least two years since first
psychotic episode; and (iv) inhabitant of the city of Me´rida,
Yucata´n, where the hospital is located. Exclusion criteria
were (i) a DSM-IV-TR diagnosis of affective, organic, or toxic
type psychosis [25]; (ii) an intellectual disability (i.e., evident
limitations in intellectual functioning and adaptive day-to-
day conduct, the latter is expressed as conceptual, social,
and practical adaptive skills [26]) as reported by the relative
and/or the patient; and (iii) insufficient contact information.
2.1. Participants. Clinical file review produced 161 potential
cases, of which only 103 could be contacted (3 had passed
away; 55 no longer lived in the area or could not be contacted).
When invited to participate, patients and relatives were
guaranteed confidentiality and clearly informed that their
decision to participate or not would have no effect on the
attention provided by the hospital or its quality and that they
were free to withdraw from the study at any time. A total of
66 cases were included in the final sample; informed consent
forms were signed by participants and/or their relatives with
no financial compensation involved.
Over half the patients (𝑛 = 38, 57.6%) were female. Mean
current patient age was 36.2 years (SD = 9.8) and that at
psychosis onset was 29.4 years (SD = 9.6); no differences
were observed by sex. Average time since onset was 6.9 years
(SD = 2.1, range 3.8–14.0). Thirty-seven (56.1%) participants
had an elementary and/or partial middle school education
level (up to 9th grade), and the remaining 29 (43.9%) had a
partial/completemiddle or high school education level. None
of the participants was hospitalized at the time of assess-
ment. In terms of DSM-IV-TR [25] diagnoses, 45 patients
had presented schizophrenia (25 residual, 16 paranoid, 3
disorganized, and 1 catatonic) and 21 had experienced other
types of schizophrenia spectrumpsychoses (9 schizoaffective,
7 delusional, 2 schizophreniform, 2 brief, and 1 unspecified).
Of the relatives (𝑛 = 65), 48 (72.7%) were female and
mean age was 48.7 (SD = 16.5), with no differences by sex.
Forty (61.5%) had elementary and/or partial middle school
education levels (up to 9th grade) and the remaining 25
(38.5%) had partial/complete middle or high school educa-
tion levels. Relatives included 30 (46.2%) parents, 17 (26.2%)
spouses, 7 (10.8%) siblings, 6 (9.2%) offspring, and 5 (7.7%)
other relatives (grandmother, aunt, nephew, mother-in-law,
and sister-in-law). All relatives reported having contact with
the patient at least once a week, and 58 (89.2%) lived with the
patient.
2.2. Instruments. Patients and relatives were interviewed
following module B (psychotic symptoms) of the Structured
Clinical Interview for DSM-IV Axis I Disorders (SCID-I)
[27] to determine whether or not characteristic symptoms of
psychosis had been present at any time from onset until time
of assessment. This module includes delusions (reference,
persecutory, grandiose, somatic, and other delusions such
as religious, guilt, jealousy, and erotomania); hallucinations
(auditory, visual, tactile, and other hallucinations such as
gustatory and olfactory); catatonic behavior; grossly disorga-
nized behavior; inappropriate affect and speech; and negative
symptoms. Symptom profile was complemented with infor-
mation from clinical records.
Current patient clinical status was rated with the Positive
and Negative Syndrome Scale (PANSS) [28, 29]. This instru-
ment lists thirty symptoms to be scored by the interviewer
from 1 (absent) to 7 (extreme); symptom dimensions are
classified as positive (7 items), negative (7 items), and general
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Table 1: Patients’ symptom profile (𝑁 = 66).
Total and percentage of patients [𝑛 (%)] who have ever presented characteristic psychotic symptoms as listed in the
SCID-I
Delusions 13 (19.7)1 Hallucinations 26 (39.4)1 Other psychotic symptoms 40 (60.6)1
Reference 61 (92.4) Auditory 53 (80.3) Catatonic behavior 18 (27.3)
Persecutory 53 (80.3) Visual 38 (57.6) Grossly disorganized behavior 25 (37.9)
Grandiose 38 (57.6) Tactile 16 (24.2) Inappropriate affect 19 (28.8)
Somatic 32 (48.5) Other hallucinations 11 (16.7) Inappropriate speech 26 (39.4)
Other delusions 45 (68.2) Negative symptoms 47 (71.2)
Current symptomatology as assessed with the PANSS2 [mean (SD)]
Positive 1.51 (0.59) PANSS items proposed as remission criteria3: 41 (62.1%) patients in remission
Negative 1.78 (0.84) Delusions 2.02 (1.38) Mannerisms/posturing 1.24 (0.84)
General 1.63 (0.49) Unusual thought content 1.52 (0.93) Blunted affect 1.82 (1.14)
Total 1.64 (0.53) Hallucinatory behavior 1.44 (0.91) Social withdrawal 2.27 (1.60)
Conceptual disorganization 1.64 (1.16) Lack of spontaneity 1.55 (1.13)
1Number and percentage of patients who had experienced many symptoms (≥3) of the category.
2Mean scores are reported between the ranges of 1 (absent) and 7 (severe).
3Simultaneous ratings of mild or less (≤3) on all required items.
(16 items). Symptomatic remission was considered as a 6-
month period of simultaneous ratings of mild or less (≤3)
on eight selected items: delusions; unusual thought content;
hallucinatory behavior; conceptual disorganization; manner-
ism/posturing; blunted affect; social withdrawal; and lack of
spontaneity [30].
The Angermeyer and Klusmann scale, originally tested in
patient and relative samples [7, 11], was applied to participant
beliefs regarding the etiology of the patient’s psychosis.
The authors translated the scale, which consists of a list of
thirty possible causes to which participants must respond
whether it is “not” (=1), “possibly” (=2), “likely” (=3), or “very
likely” (=4) a cause of psychosis. Items are grouped into five
etiological categories: biology, personality, family, society, and
esoteric. This instrument has reported satisfactory psycho-
metric qualities [31] in patient and relative samples [12].
2.3. Statistical Analysis. Descriptive statistics were generated
for the patients’ symptom profile and for the etiological attri-
bution of psychosis by patients and their relatives. A series of
two-way mixed (split-plot) factorial ANOVAs were used to
explore the main effect of symptom profile and its interaction
effect with etiological attribution. “etiological category” was
entered as the intrasubject factor, with 5 levels: biology, per-
sonality, family, society, and esoteric. “Symptom profile” was
considered the intersubjects factor. Patients were assigned
to one of two groups for each SCID-I symptom, depending
on whether they had ever experienced that symptom or not
in the course of their disorder. The total number of SCID-I
symptoms was generated by category (delusions, hallucina-
tions, and other psychotic symptoms), and patients divided
into two groups: those with few symptoms (<3) or many
symptoms (≥3). Based on PANSS remission criteria, the
patients were classified as in remission or nonremission.
Tests were run independently for attribution of psychosis by
patients and by their relatives.
3. Results
The most common symptoms experienced by patients were
delusions of reference (92.4%), followed by persecutory delu-
sions (80.3%) and auditory hallucinations (80.3%) (Table 1).
As mentioned, patients were also categorized as having
few or many psychotic symptoms (delusions, hallucinations,
or others). When considered individually, other psychotic
symptoms were not the most common (from 27.3 to 71.2%),
but this category contained the most patients reporting three
or more symptoms (60.6%). Negative symptoms exhibited
the highest PANSS score, although overall current clinical
symptoms were mild or absent since some patients could be
considered as in remission. Of the single selected items for
remission criteria, delusions and social withdrawal had the
highest scores but remained mild (≤3).
Symptom severity prevented four patients from respond-
ing to the questionnaire; and in one case the patient could
not identify a relative available for interviewing. As a result,
of the 66 identified cases, 62 patients and 65 relatives reported
their beliefs on etiological attribution of psychosis (Table 2).
Patients and relatives concurred in pointing out “society” as
the principal cause and “esoteric” as a minor cause. Appli-
cation of t-tests indicated that the levels of attribution to
each category did not differ significantly between patients and
relatives. The repeated measures one-way ANOVA identified
significant differences in degree of attribution between etio-
logical categories, among both patients (𝐹
(4,244)
= 16.75; 𝑝 ≤
0.001) and relatives (𝐹
(4,256)
= 22.99; 𝑝 ≤ 0.001).These differ-
ences were mainly due to attribution to esoteric factors being
significantly lower in comparison to attribution to other types
of factors (i.e., biology, personality, family, and society).
Overall symptom profile did not have a significant main
effect on etiological category scoring, with few excep-
tions. Patients who had experienced auditory hallucinations
(𝐹
(1,60)
= 4.080; 𝑝 ≤ 0.05) or three or more types of delusions
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Table 2: Etiological attribution of psychotic illness reported by patients and their relatives.
Patients (𝑛 = 62) Relatives (𝑛 = 65)
Mean (SD) Mean (SD)
Biology
Disturbance of brain biochemistry, hereditary factors, birth trauma, brain injury, organic
disease external to brain, infectious brain disease 1.73 (0.58) 1.84 (0.65)
Personality
Avoidance of everyday life problems, failure in life, lack of willpower, too bright or
intelligent, too ambitious, drug/alcohol abuse 1.98 (0.62) 1.82 (0.61)
Family
Broken home, lack of parental love, parent attitude hostile-rejecting, father too severe,
overprotective mother, parental expectations too high 1.84 (0.75) 1.93 (0.79)
Society
Stressful life events, constant strain in school/job, troubles in marriage/partnership,
society, loneliness, influence of bad friends 2.12 (0.67) 2.07 (0.73)
Esoteric
Possession by evil spirits, lack of vitamins, punishment by God, unfavorable horoscope,
radiation, environmental pollution 1.46 (0.52) 1.36 (0.46)
Significant post hoc results in patients Significant post hoc results in relatives
Biology < personality∗ Family < society∗ Biology > esoteric∗∗∗ Family > esoteric∗∗∗
Biology < society∗∗∗ Family > esoteric∗∗ Personality < society∗∗ Society > esoteric∗∗∗
Biology > esoteric∗ Society > esoteric∗∗∗ Personality > esoteric∗∗∗
Personality > esoteric∗∗∗
Individual item scores: 1 (not a cause), 2 (possibly a cause), 3 (likely a cause), 4 (very likely a cause).
∗
𝑝 ≤ 0.05, ∗∗𝑝 ≤ 0.01, and ∗∗∗𝑝 ≤ 0.001.
(𝐹
(1,60)
= 9.381; 𝑝 ≤ 0.01) scored significantly higher in their
attributions, regardless of etiological category. Relatives of
those patients who had experienced other types of delusions
(𝐹
(1,63)
= 7.403; 𝑝 ≤ 0.01) or three or more types of delusions
(𝐹
(1,63)
= 6.707; 𝑝 ≤ 0.01) also scored significantly higher in
their attributions, regardless of etiological category.
No significant symptom profile × etiological category
interaction was found when considering SCID-I symptoms
individually or by category (𝐹 < 1). However, differences
were observed when considering PANSS remission criteria
and its interaction with etiological category (𝐹
(4,240)
= 2.428;
𝑝 ≤ 0.05). Attribution of psychosis to biological, societal,
or esoteric factors was quite similar in both patient groups,
but those in nonremission scored personality (mean = 2.20)
and family (mean = 2.06) factors notably higher as causes of
psychosis than patients in remission (personalitymean= 1.87;
family mean = 1.73) (Figure 1). Among relatives, all symptom
profile × etiological category interactions were not significant
(𝐹 < 1).
4. Discussion
Research into the beliefs surrounding the etiology of mental
disorders has gained momentum because understanding
these beliefs can help to model community attitudes toward
psychosis (e.g., stigmatization of patients) and identify
unwarranted delays in seeking treatment [31–33]. Schizo-
phrenia and related psychoses are characterized by a complex
and often severe symptomatology. In response, interest has
been focused on exploring how patients and their relatives
interpret this mental condition and then consequently act
when requesting and receiving treatment [5, 8]. Unlike
previous studies on the subject, the present study considered
the etiological attributions of psychosis of both patients and
their relatives as a factor that can be influenced by the past
and current profiles of psychotic symptoms.
The first study goal was to identify, in a sample from
Mexico, the most common factors identified by patients and
their relatives as the causes of the patient’s psychotic disorder.
Patients’ appraisal and relatives’ appraisal of etiological fac-
tors were generally similar and coincided in indicating social
factors as themost important causes of psychosis and esoteric
factors as the least. The attribution of psychosis mainly
to social factors in the present sample concurs with prior
reports from other countries such as Germany and Austria
[6, 11, 13, 22], and Greece [6, 34]. However, cause attribution
varies widely among reports from different countries. South-
African, first-episode psychosis patients, attributed their
condition mainly (49%) to spiritual causes [10]. In one study
in Tunisia, patients’ relatives attributed the patient’s psychosis
mainly (76.9%) to religious causes, such as “God’s will or
fate” or “God’s punishment,” followed by biological causes
(59.3%), and magical etiologies such witchcraft and spirit
possession (47.3%) [14]. Another study in Tunisia found that
63.3% of a sample of Tunisian mothers of adolescents with
first-episode psychosis attributed the child’s symptomatology
to spirit possession, while 77.3% considered it to be just a
behavioral disorder [16].
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Figure 1: Mean attribution scores by etiological category.
Other studies have shown that ethnicity, rather than
country of origin, has the greatest effect on etiological beliefs.
A study including patients from different ethnic groups living
in the UK found black and Asian individuals (all first- to
third-generation immigrants) attributed their mental disor-
der mainly to supernatural causes, whereas white individ-
uals, mostly (95.6%) nonmigrant British and Irish patients,
attributed it mainly to individual factors [8]. In the United
States, another study found that relatives of African-
American patients attributed psychosis mainly to biological
causes [12]. This diversity in attribution patterns highlights
the need for further research across various groups; studies
are still needed in community, patient, and relatives samples
but also need to include different ethnic populations residing
in one ormore countries. Results from broader studies would
allow a more thorough understanding of how patients and
relatives interpret and cope with psychosis and help to design
and implement targeted interventions.
The second study goal was to explore the possible effect
of past and present psychotic symptom profile on etiological
attributions. Whether or not a patient had experienced char-
acteristic symptoms during the course of psychosis appar-
ently exhibited no significant interaction with attribution to
a specific etiological category in either patients or relatives.
Assessment of past symptoms is retrospective, meaning that
there is a possibility of interaction with attribution of psy-
chosis in the present sample. All cases included in the study
had, at some point, been under treatment at the host hospital,
and patients and relatives could therefore have had some
orientation about psychosis, which could partially homoge-
nize their etiological beliefs, regardless of symptomatology.
Another possibility is that individuals with similar etiological
beliefs, like those in the present sample, were more likely to
seek attention at amental health hospital. Lack of significance
in the results should be taken as encouragement to implement
further research with more controlled methods that would
allow inclusion of other possible influencing factors andmore
comprehensive results interpretation.
In the present sample, current clinical status had no
significant interaction with etiological attribution in rela-
tives but exhibited a significant interaction with patients’
attribution. Patients in nonremission scored personality and
family factors notably higher as causes than did patients in
remission. Attribution to internal factors, such as personality,
can expose patients to additional distress and feelings of guilt
for having caused his/her mental disorder and/or for being
unable to overcome it. Attribution to family can foment con-
flict and resentment between familymembers. It is important
to bring these issues into clinical practice, provide patients the
opportunity to openly discuss these beliefs, and then learn
healthy coping skills to apply in themselves and with their
families.
Thepresent study contributes to a better understanding of
how patients with psychosis and their relatives interpret this
disorder. An individual’s etiological beliefs about psychosis
are neither right nor wrong, regardless of how much they
agree or not with the current tenets of psychiatry. Systematic
research has indeed generated significant amounts of data on
the causes of psychosis, but comprehension of its etiology
still remains limited, with a wide gap between “findings” and
“understanding” [35]. Clinicians tend to emphasize and favor
the biomedical aspects of psychosis in the belief that acknowl-
edging and accepting themwill promote treatment adherence
and contribute tomore positive outcomes [36].This approach
requires caution, however, since belief in biomedical causality
seems to be linked to negative attitudes toward patients, such
as perceptions of dangerousness and unpredictability, fear,
and a preference for social distance [32, 37, 38]. In addition,
it is unprofessional and unethical to patronize or dismiss lay
beliefs; indeed, they need be respected and integrated into the
process of coping with the mental disorder. Acknowledging
patients’ and relatives’ beliefs about the mental disorder
communicates practitioner interest and credibility, encour-
aging their involvement and increasing their commitment
to treatment. It can also help clinicians to identify possible
feelings of guilt, shame, or despair while treating the patient
and managing the intrafamily dynamic. Allowing patients
and family to openly express their beliefs about the disorder
they are experiencing can be therapeutic in itself, helping
them to feel understood and valued, to play an active role
in an intervention model based on shared decision-making,
and to have a sense of independence and efficacy [39–
42]. Biomedical explanations can and should be offered, but
without disregarding or disqualifying the patients’ or families’
etiological beliefs. In other words, mental health profession-
als face the challenge of integrating all the interpretations in a
given case, rather than prioritizing their own over the appar-
ently incompatible ones of the patient and his/her family [43].
It is to mental health practitioners’ benefit to adopt a more
eclectic treatment approach within a more open framework
that will enable them to encompass local/ethnic beliefs along
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with traditional psychomedical treatments in therapy, since it
will increase overall therapeutic efficacy [44].
The study design contains some primary limitations in
terms of variable control that could influence attribution
results, including previously held beliefs about mental dis-
orders and their treatment, exposure to formal informa-
tion about psychosis, the number and severity of psychotic
episodes experienced, and personality traits. Nonetheless, the
present results do suggest that current symptoms relate to
attributions, particularly in patients. However, assuming a
direct causal relationship in either direction would be inap-
propriate. A design including assessment at onset and follow-
up at various time points would improve observation of psy-
chosis evolution and how beliefs respond to different stages
in case evolution. Finally, the studied sample was limited to
inhabitants of a large urban area, leaving open the question
of whether this same attribution pattern would also occur
in small rural communities where social support plays an
important role in individualmental health, butwhere esoteric
beliefs are more widely held.
5. Conclusions
In the present results, Mexican patients with psychosis and
their relatives attributed the disorder mainly to social factors.
The relatives’ attributions were generally not influenced by
patient clinical profile. For patients, differences existed only
in response to current clinical status, with those in nonre-
mission scoring higher on personality and family factors.
Acknowledging patients’ and relatives’ beliefs about mental
disorders at onset and during treatment and follow-up needs
to become a regular aspect of clinical practice to increase
practitioner involvement and consequently improve treat-
ment efficacy and recovery.This is particularly vital inmental
conditions with severe and/or persistent symptoms, such as
psychosis.
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